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SUMMARY : Malignant fibrous histiocytoma (MFH) arising in the lung of an autopsy 
case, a 52-year-old man, is reported with immunohistochemical findings. In most areas, 
a storiform patterns with fibroblast-like cells and histiocyte-like cells were noted. Extensive 
carcinoma invasion and multiple metastases were found in many organs such as 
mediastinum, heart, aorta, left pleural cavity, abdominal wall, omentum, peritomeum, liver, 
intestine, adrenal and kidneys. The tumor was mainly composed of spindle cells and 
had storiform and herring-bone patterns. immunohistochemically, these tumor cells were 
demonstrated to possess vimentin, alpha-l-antitrypsin, alpha-l-antichymotrypsin and 
lysozyme.
       INTRODUCTION 
 Since malignant fibrous histiocytoma (MFH) 
was described in the 1960s'7' 19), it has been 
recognized as the most common soft tissue 
sarcoma of older adults23'. The usual primary 
sites of MFH are the deep musculature of 
extremities, retroperitoneum, and trunk. Al-
though over 75 % of deep-seated soft tissue MFH 
metastasizes to the lung, primary MFH of the 
lung is rare. The common primary pulmonary 
sarcomas have been reported to be leio-
myosarcoma and fibrosarcoma. 
 MFH is characterized by both histiocyte-like 
and fibroblast-like cells usually arranged in a 
storiform pattern2, s, 23) By routine light 
microscopic examination, however, MFH may 
be difficult to be distinguished from other 
sarcomas9'. Therefore, immunohistochemical 
and electron microscopic examinations may be 
required for diagnosis.
 We herein present an autopsy case of primary 
MFH of the lung, confused with fibrosarcoma 
and diagnosed by immunohistochemical study.
        CASE REPORT 
 A 52-year-old man was admitted to our 
hospital in July, 1989, because of a chronic cough 
of two year's' duration. Two weeks previously, 
the cough became productive of small amount 
of sputum which was occasionally blood-
streaked. A chest X-ray film and chest CT scan 
showed an almost homogeneous density 
measuring 10 cm in diameter and reaching the 
aorta in the left upper lung. Left pleural effusion 
was also noted. Bronchoscopy demonstrated a 
finger-like projection with pulsation within the 
lumen of the left upper bronchus. On August 
4, a bone scintigraphy revealed a metastasis to 
the left 8th rib. He underwent chemotherapies 
of cisplatin and vindesine from August 21, since 
malignant tumor of the lung with metastases
was strongly suspected. In September, he 
expectorated sputum with tumor fragments 
three times. One of the experctorated specimens 
showed the appearance of poorly-differen-
tiated squamous cell carcinoma which had 
eosin-stained cytoplasm, many mitoses, and a 
few PAS-positive tumor cells with vacuoles. 
The other specimens revealed the histological 
appearance of fibrosarcoma which contained 
spindle-cells, interlacing fibers, and a few 
mitoses. On November 7, lymphokine activated 
killer-cell (LAK) therapy`' was performed. On 
November 24 and December 22, cytotoxic T 
lymphocyte (CTL) therapy 7) was also done. The 
tumor, however, showed no response to these 
treatments. Multiple metastases from the pul-
monary tumor were noted in the back, liver, 
stomach, ribs, sternum, and iliac bone. Pleural 
effusion and ascites appeared and gradually 
increased. Hemorrhagic ascites was also dem-
onstrated by abdominal puncture, suggesting 
rupture of metastatic gastric tumor or 
perforation of the digestive ulcer, and his 
condition deteriorated due to respiratory 
insufficiency. He died of hemorrhagic shock on 
March 1, 1990. Postmortem examination was 
performed about one and a half hours after 
death.
nuclear chromatin pattern varied from vesicular 
to evenly dispersed. A single, small nucleolus 
was usually present. Most areas of the lesion 
showed a distinct storiform pattern (Fig. 2) 
suggesting MFH, but few form cells or giant 
cells were noted. However, herring-bone-like
Fig. 1. Gross appearance of the primary tumor in 
      the upper lobe of the left lung with central 
       necrosis.
          RESULTS 
 Gross findings : The left lung weighed 900 gm. 
A solitary tumor of necrotic mass, man's fist 
size, was found in the upper lobe involving the 
left main bronchus, and the tumor was poorly 
delineated and had hemorrhahic central ne-
crosis (Fig. 1). The tumor was seen to invade 
posterior mediastinum, aortic wall, and left 
atrium. Multiple metastases were found in the 
left pleural cavity, abdominal wall, omentum, 
peritoneum, liver, right adrenal, both kidneys 
and intestine resulting in conglomeration of 
entire intestinal loop. About 5 mm diameter 
hole with clear margin was seen at the greater 
curvature of the stomach. 
 Microscopic finding : The tumor of the lung 
consisted of fibroblast-like and histiocyte-like 
cells. The fibroblast-like cells were spindle-
shaped and contained a single elongated nucleus 
surrounded by a thin rim of cytoplasm. The
Fig. 2. Storiform pattern with a predominance of 
      spindle-shaped fibroblast-like cells is noted. 
      (Hematoxylin Eosin X150)
Fig. 3. High-power view of several pleomorphic 
      tumor giant cells (Hematoxylin Eosin x 300)
Fig. 4. Alpha-1-antichymotrypsin (A) and vimentin (B) are positively demonstrated in tumor 
      cells (PAP stain X300)
areas suggesting fibrosarcoma were occa-
sionally present. The histiocyte-like cells were 
somewhat irregular outline and had abundant, 
eosinophilic cytoplasm than the fibroblast-like 
cells. Their nuclei were usually round to oval 
or vesicular, and possessed a single prominent 
nucleolus. The tumor cells exhibited moderate 
nuclear pleomorphism and hyperchromasia 
with up to 15 mitoses per 10 high-power field 
(HPF). The histological features of the 
metastatic lesion were almost identical to those 
of the primary lesion. However, the metastatic 
lesion contained occasional giant cells and 
showed more variegated histological appearance 
than the primary lesion. No malignant cells 
wrer noted in the stomach with perforated 
ulcerated lesion. 
 Immunohistochemical Findings : Formalin-
fixed, paraffin-embedded specimens were im-
muno-histochemically examined using per-
oxidase-anti -peroxidase (PAP) techniques, as 
previously described". Almost all the fibro-
blast-like, histiocyte-like, and giant cells showed 
diffuse positive cytoplasmic staining for 
vimentin, alpha-l-antitrypsin, alpha-l-antichy-
motrypsin, and lysozyme (Fig. 4A and B). There 
was no immunoreactivity for antibodies for 
keratin, desmin, S-100 protein, and neuron-
specific antigen, and anti-smooth muscle anti-
body.
         DISCUSSION 
 Primary pulmonary MFH is much rarer, and 
only fewer than 30 cases have been reported.
It ranks third in incidence of pulmonary 
sarcomas, following leiomyosarcoma and fibro-
sarcoma6' 15'. In Japan, it comes third, following 
leiomyosarcoma and rhabdomyosarcomal4> 
 Patients with MFH of the lung must be 
carefully evaluated to rule out a metastatic 
origin, because MFH is primarily a tumor of the 
soft tissues of the extremities" 23) and metastases 
frequently appear in the lung'). However, 
patients have rarely presented with pulmonary 
metastases before the primary tumor was 
identified3' 23) In our case, although wide spread 
metastases were seen, the primary tumor was 
in the left lung, judging from the clinical course 
in which the tumor was first seen in the left 
lung. 
 It is speculated that few accurately diagnosed 
cases of MFHs have been reported so far in the 
literature, because of their low incidence above 
described and of being classified as a pleo-
morphic variant of fibrosarcoma, leiomyosar-
coma, liposarcama, or rhabdomyosarcoma prior 
to the recognition of MFH as a distinct neo-
plasm'). There also may be tendency to inter-
pret pleomorphic lung sarcomas as poorly 
differentiated carcinoma6'. 
 The lesions in our case showed storiform 
pattern with fibroblast-like and histiocyte-like 
cells. Such morphologic pattern is often pres-
ent in most cases of MFH, but not specific for 
MFH2'. MFH presents an extremely wide range 
in its cellular composition and pattern, not only 
from tumor to tumor, but also frequently in 
different portions of the same tumor"). In fact, 
in our case, herring-born-like pattern was seen
in the pulmonary lesion. The predominantly 
fibroblastic types of MFH may similar to fibro-
sarcoma, maligant schwannoma, synovial sar-
coma, or leiomyosarcoma16'. To support the 
light microscopic diagnosis of MFH, electron 
microscopic and immunohistochemical exam-
ination is required'. 
  Antibodies to the various proteins are useful 
in distinguishing between epithelial and mesen-
chymal tumors. This is based on the relatively 
stable cell-type-specific expression of inter-
mediate filament proteins in malignant tumor 
cells as follows ; keratins in epithelial, vimentin 
in mesenchymal, desmin and muscle-specific 
antigen in muscular, neuron-specific antigen in 
neural, and S-100 protein in neurosarcoma 
(malignant schwannoma), liposarcoma, and 
malignant melanoma" 18'. Numerous immu-
nohistochemical studies of MFH have been 
reported that the cells of MFH contain only 
vimentin5' 18', both desmin and vimentin1, 
lysozyme, alpha- l-antitrypsin, and alpha-1-
anti chymotrypsin1, 10', or subunit A of factor 
XIII16'. 
  Thus, the immunohistochemistry of inter-
mediate filaments does not offer any universal 
defining pattern for MFH9' 12'. However, Roholl 
et a120' consider that the presence of alpha-l-
antichymotrypsin or one of the other markers 
favors the diagnosis of MFH, and Miettinen and 
Soini12' stated that the immunohistochemical 
study of MFH remains a diagnosis by exclusion 
rather than representing a specifically recog-
nizable entity. The tumor cells in our case 
reacted to antibodies for vimentin, lysozyme, 
alpha-l-antitrypsin, and alpha- l-antichymo-
trypsin. However, these tumor cells showed no 
definite reaction to antibodies for keratin, 
desmin, neuronspecific antigen, and S-100 pro-
tein, and smoothmuscle antibody. Therefore, 
we ruled out the following diagnosis ; carci-
noma or leiomyosarcoma, rhabdomyosarcoma, 
malignant schwanoma, malignant melanoma, 
and liposarcoma. Fibrosarcoma was also ruled 
out, because it has no reactivity for alpha-l-
antichymotrypsins, 20) 
  The reported prognosis in patients with pri-
mary MFH of the lung is poor'). The predictive 
features of a worse prognosis are 1) advanced 
stage at diagnosis, 2) incomplete excision of the
sarcoma (biopsy only), 3) tumor invasion of the 
mediastinum and chest wall seen at initial 
diagnosis, 4) recurrence or metastasis2L' 24'. In 
the present case, the initial examination revealed 
that the tumor invaded into the' left bronchi and 
attached to the aorta of the tumor, and the later 
examination showed multiple metastases. 
Yousem et aL24' reported that half of the patients 
with. MFH in the lung had metastatic patterns 
which reflect the propensity for vascular 
invasion of MFH in that distant disease was 
found in the brain, liver, and kidneys. Thus, 
the prognosis of the lung is poor, but surgical 
resection offers the chance of a cure'' 22'. The 
role of either chemotherapy or radiotherapy as 
primary or adjuvant treatment in MFH is 
presently unclear2L'. Lymphokine activated 
killer-cell (LAK) therapy and cytotoxic T 
lymphocyte (CTL) therapy are immunotherapies 
expected as new treatments against malignant 
tumors. Kitsukawa7' reported that CTL therapy 
produced effects on the life prolongtion of the 
patients with carcinomas in the terminal stage. 
However, CTL therapy produced no effect on 
the MFH in the present case. Clinical signifi-
cance of various types of treatments must await 
the more studies of their use against pleo-
morphic sarcomas and their metastases.
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